These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32081023)

  • 1. The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing.
    Maclean W; Singh R; Mackenzie P; White D; Benton S; Stebbing J; Rockall T; Jourdan I
    Ann R Coll Surg Engl; 2020 Apr; 102(4):308-311. PubMed ID: 32081023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.
    von Wagner C; Stoffel S; Freeman M; Laszlo H; Nicholson BD; Sheringham J; Szinay D; Hirst Y
    Br J Gen Pract; 2018 Nov; 68(676):e757-e764. PubMed ID: 30297435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
    Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Straight-to-test for the two-week-wait colorectal cancer pathway under the updated NICE guidelines reduces time to cancer diagnosis and treatment.
    Christopher J; Flint TR; Ahmed H; Dhir N; Li R; Macfarland K; Ng D; Ng J; O'Neill C; Te Water Naudé A; Sloan K; Hall NR; Powar MP
    Ann R Coll Surg Engl; 2019 May; 101(5):333-339. PubMed ID: 31042431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid.
    Valentín-López B; Ferrándiz-Santos J; Blasco-Amaro JA; Morillas-Sáinz JD; Ruiz-López P
    Fam Pract; 2012 Apr; 29(2):182-8. PubMed ID: 21976660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
    Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
    Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
    Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
    Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Pande R; Leung E; McCullough P; Smith S; Harmston C
    Dis Colon Rectum; 2014 Jan; 57(1):70-5. PubMed ID: 24316948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increasing burden of the 2-week wait colorectal cancer pathway in a single centre: the impact of faecal immunochemical tests.
    Farkas N; O'Brien JW; Palyvos L; Maclean W; Benton S; Rockall T; Jourdan I
    Ann R Coll Surg Engl; 2024 Apr; 106(4):338-343. PubMed ID: 36688865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways.
    Gerrard AD; Coxon J; Maeda Y; Theodoratou E; Dunlop MG; Din FVN
    BJS Open; 2024 Sep; 8(5):. PubMed ID: 39404039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
    Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
    Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Referral Rates for Genetic Assessment of Patients With Multiple Adenomas in United Kingdom Bowel Cancer Screening Programs.
    Alexander JL; Johnston BJ; Smith TJ; Yong KK; Marshall SM; Fawkes JDC; Martin JP; Seward EW; Saunders B; Monahan KJ
    Dis Colon Rectum; 2021 Sep; 64(9):1058-1063. PubMed ID: 34039904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.